These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2966141)

  • 21. The activity of the 4 quinolone Ro 23 6240 and the cephalosporins Ro 15 8074 and Ro 19 5247 against penicillin sensitive and resistant gonococci.
    Easmon CS; Woodford N; Ison CA
    J Antimicrob Chemother; 1987 Jun; 19(6):761-5. PubMed ID: 3112100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of gonorrhoea and susceptibility to antimicrobials of PPNG and non-PPNG strains in Jamaica.
    King SD; Brathwaite AR; Dillon JR
    Genitourin Med; 1987 Dec; 63(6):365-70. PubMed ID: 3123360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibility of non-penicillinase and penicillinase-producing Neisseria gonorrhoeae strains isolated in Tripoli, Libya.
    Elghoul MT; Joshi RM
    Int J STD AIDS; 1990 Sep; 1(5):343-5. PubMed ID: 2151509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of temocillin against Neisseria gonorrhoeae including penicillinase-producing strains.
    Jephcott AE; Egglestone SI
    Drugs; 1985; 29 Suppl 5():18-23. PubMed ID: 3161721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of PPNG strains & in vitro sensitivity pattern of Neisseria gonorrhoeae in Varanasi (Uttar Pradesh, India).
    Mishra D; Singh G
    Indian J Med Res; 1989 Jul; 89():243-8. PubMed ID: 2509343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The in-vitro activity of CI-934 compared with that of other new 4-quinolones and nalidixic acid.
    King A; Shannon K; Slegg J; Phillips I
    J Antimicrob Chemother; 1986 Aug; 18(2):163-9. PubMed ID: 3463557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro susceptibility of recent isolates of Neisseria gonorrhoeae to cephalosporins of different generations and penicillin G: a comparative evaluation.
    Korting HC
    Dermatologica; 1984; 168(2):67-72. PubMed ID: 6421633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vitro antigonococcal activity of rosoxacin (WIN 35213).
    Warren CA; Shannon KP; Phillips I
    Br J Vener Dis; 1981 Feb; 57(1):33-5. PubMed ID: 6781706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility of penicillinase-producing Neisseria gonorrhoeae in Ibadan to cefoxitin.
    Ogunbanjo BO; Osoba AO; Ochei J
    Afr J Med Med Sci; 1984; 13(3-4):151-4. PubMed ID: 6099976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of uncomplicated gonorrhoea with rosoxacin (acrosoxacin).
    Lim KB; Rajan VS; Giam YC; Lui EO; Sng EH; Yeo KL
    Br J Vener Dis; 1984 Jun; 60(3):157-60. PubMed ID: 6428698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of Ro 13-9904, cefuroxime, cefoxitin, and ampicillin against Neisseria gonorrhoeae.
    Yoshikawa TT; Shibata SA; Herbert P; Oill PA
    Antimicrob Agents Chemother; 1980 Aug; 18(2):355-6. PubMed ID: 6778381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
    Renaudin H; Quentin C; de Barbeyrac B; Bebear C
    Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Development of the sensitivity to antibiotics in strains of Neisseria gonorrhea isolated in Touraine over a 5-year period].
    Pinon G; Quentin R; Laudat P; Vargues R
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):554-6. PubMed ID: 2935773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penicillinase-producing Neisseria gonorrhoeae isolates from different localities in south east Asia. Susceptibility to 15 antibiotics.
    Ng WS; Chau PY; Ling J; Echeverria P; Rockhill R; Arnold K
    Br J Vener Dis; 1983 Aug; 59(4):232-6. PubMed ID: 6409343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-dose treatment of uncomplicated acute gonococcal urethritis in Ethiopian men: comparison of rosoxacin, spectinomycin, penicillin, and ampicillin.
    Habte-Gabr E; Geyid A; Serdo D; Biddle J; Perine PL
    Sex Transm Dis; 1987; 14(3):153-5. PubMed ID: 2958947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of six quinolone derivatives against Neisseria gonorrhoeae.
    Lefèvre JC; Tempesta MC; Gaubert E; Lareng MB
    Chemotherapy; 1988; 34(4):315-7. PubMed ID: 2850138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance in gonococci isolated in the WHO Western Pacific Region to various antimicrobials used in the treatment of gonorrhoea, 1997. WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme-WHO WPR GASP.
    Commun Dis Intell; 1998 Dec; 22(13):288-91. PubMed ID: 9893340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A; Phillips I
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of nine antibacterial agents on penicillinase- and nonpenicillinase-producing Neisseria gonorrhoeae isolated from clinical specimens obtained in northern Norway.
    Melby K; Størvold G; Leinslie T; Falk ES
    Chemotherapy; 1985; 31(5):346-50. PubMed ID: 3931991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term antibiotic susceptibility pattern of strains of Neisseria gonorrhoeae isolated in Czechoslovakia in the years 1957-1982.
    Hejzlar H; Drazdáková M; Podaná B; Kvicera J; Kittnar E; Hajková L; Povolná A; Sedmidubský V; Nedvídková J; Janatová E; Pellar T; Stastná L
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(4):385-95. PubMed ID: 6219159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.